You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 27 No. 4, October 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human Chromosomes and Opiates

Arthur Falek, PhD; Rusha B. Jordan; Barbara J. King, RN; Paula J. Arnold, MS; W. Douglas Skelton, MD

Arch Gen Psychiatry. 1972;27(4):511-515.


Abstract

A cytogenic study of 16 opiate addicts receiving methadone hydrochloride compared with a control population revealed an unusual number of chromosome aberrations including dicentric chromosomes and an exchange figure at 72 hours in the addicted group, but no significant increase in chromosome anomalies over the controls at 48 hours. To determine whether methadone was the drug responsible for these chromosome abnormalities an in vitro study was initiated to evaluate the effects of methadone, morphine, and quinine on peripheral blood leukocytes from nonaddicts. Chromosome studies at three times normal, normal, and one third, one sixth, and one twelfth the normal therapeutic concentrations of quinine, morphine, and methadone introduced at 24, 48, and 68 hours into 72-hour leukocyte cultures did not reveal an increased frequency of chromosome damage.



Author Affiliations

Atlanta

From the Division of Human Genetics, Georgia Mental Health Institute, Georgia Department of Human Resources (Dr. Falek, R. Jordan, B. King, and P. Arnold), the Department of Psychiatry, Emory University (Drs. Falek and Skelton), and the Psychiatric Service, Grady Memorial Hospital (Drs. Falek and Skelton), Atlanta.


Footnotes

Accepted for publication March 9, 1972.

Reprint requests to Division of Human Genetics, Georgia Mental Health Institute, 1256 Briarcliff Rd NE, Atlanta 30306 (Dr. Falek).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Oxymorphone Hydrochloride, a Potent Opioid Analgesic, Is Not Carcinogenic in Rats or Mice
Shuey et al.
Toxicol Sci 2007;96:162-173.
ABSTRACT | FULL TEXT  

Evidence That Oxymorphone-Induced Increases in Micronuclei Occur Secondary to Hyperthermia
Shuey et al.
Toxicol Sci 2007;95:369-375.
ABSTRACT | FULL TEXT  

Subchronic Studies of Tripelennamine in Fischer 344 Rats
Jackson and Blackwell
International Journal of Toxicology 1991;10:493-502.
ABSTRACT  

Heroin and Chromosome Damage
Falek
Arch Gen Psychiatry 1980;37:227-228.
ABSTRACT  

Chromosomes in Patients Receiving Methadone and Methadyl Acetate
Matsuyama et al.
Arch Gen Psychiatry 1978;35:989-991.
ABSTRACT  

Narcotic Dependency in Pregnancy: Methadone Maintenance Compared to Use of Street Drugs
Stimmel and Adamsons
JAMA 1976;235:1121-1124.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.